Impact of next-generation sequencing on routine clinical practice and patient inclusion in molecularly targeted clinical trials: a retrospective cohort analysis
Although a substantial fraction of patients harbored actionable alterations, trial inclusion remained low at our center. Improving access requires better physician awareness of available clinical trials to optimize patient enrollment.
Authors
- Pierre Rivet
- Birama Ndiaye
- David Tougeron (ORCID: https://orcid.org/0000-0002-8065-9635)
- Camille Evrard (ORCID: https://orcid.org/0000-0003-3147-1350)
- Ulrich Cortes
- Marine Martel
- Nicolás Isambert (ORCID: https://orcid.org/0000-0003-3596-2114)
- Mathieu Faigner
- Lucie Karayan‐Tapon (ORCID: https://orcid.org/0000-0002-2875-7190)
- Jade Duche
Institutions
- Université de Poitiers (FR)
- Centre Hospitalier Universitaire de Poitiers (FR)
Publication Details
- Journal
- Clinical & Translational Oncology
- Published
- 2025-10-29
- DOI
- https://doi.org/10.1007/s12094-025-04086-7
- Primary Topic
- Genomics and Rare Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00